GEOSPACE TECHNOLOGIES CORP (GEOS) Deferred Income Tax Expense (Benefit) USD 2010 - 2022

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Geospace Technologies Corp annual/quarterly Deferred Income Tax Expense (Benefit) history and growth rate from 2010 to 2022.
  • Geospace Technologies Corp Deferred Income Tax Expense (Benefit) for the quarter ending December 31, 2022 was -$6 K, a 500% decline year-over-year.
  • Geospace Technologies Corp annual Deferred Income Tax Expense (Benefit) for 2023 was -$3 K, a 82.4% increase from 2022.
  • Geospace Technologies Corp annual Deferred Income Tax Expense (Benefit) for 2022 was -$17 K, a 667% decline from 2021.
  • Geospace Technologies Corp annual Deferred Income Tax Expense (Benefit) for 2021 was $3 K, a 98.3% decline from 2020.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 -$6 K -$5 K -500% Oct 1, 2022 Dec 31, 2022 10-Q 2023-02-09
Q4 2021 -$1 K -$7 K -117% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-09
Q4 2020 $6 K +$31 K Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-02
Q4 2019 -$25 K +$36 K +59% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-04
Q4 2018 -$61 K -$6 K -10.9% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-06
Q4 2017 -$55 K -$89 K -262% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-06
Q4 2016 $34 K -$4.89 M -99.3% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-07
Q4 2015 $4.93 M +$5.63 M Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-09
Q4 2014 -$702 K -$950 K -383% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-04
Q4 2013 $248 K -$210 K -45.9% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-05
Q4 2012 $458 K +$119 K +35.1% Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-06
Q4 2011 $339 K +$617 K Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-07
Q4 2010 -$278 K Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.